This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: Innovations of Yang Wu in Recombinant Virus Technology
Introduction
Yang Wu is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of recombinant virus technology, particularly in the preparation of recombinant adeno-associated viruses (rAAV). With a total of 4 patents, his work has advanced the understanding and application of viral vectors in gene therapy.
Latest Patents
Yang Wu's latest patents include innovative methods for preparing recombinant adeno-associated viruses. One notable patent describes a method that involves preparing a shuttle plasmid and a corresponding recombinant bacmid. This process includes integrating an rAAV gene of interest with a heterologous functional gene fragment. The recombinant bacmid contains an expression cassette of functional protein components necessary for the assembly of the rAAV. Another patent outlines a method for producing both rAAV and recombinant baculovirus. This method involves infecting an insect host packaging cell line with a recombinant baculovirus integrated with an rAAV genome and culturing the infected cells to produce the rAAV.
Career Highlights
Yang Wu is affiliated with the Chinese Academy of Sciences, where he conducts his research and development. His work has been instrumental in enhancing the efficiency and effectiveness of viral vector production, which is crucial for gene therapy applications.
Collaborations
Yang Wu collaborates with notable colleagues, including Fuqiang Xu and Xiaobin He. Their combined expertise contributes to the advancement of research in recombinant virus technology.
Conclusion
Yang Wu's innovative approaches in the field of recombinant virus technology have led to significant advancements in the preparation of viral vectors. His contributions are vital for the future of gene therapy and related applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
